- Home
- AVNW vs ESPR Comparison
AVNW vs ESPR Comparison
Compare AVNW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- ESPR
- Stock Information
- Founded
- AVNW 2006
- ESPR 2008
- Country
- AVNW United States
- ESPR United States
- Employees
- AVNW N/A
- ESPR N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- ESPR Health Care
- Exchange
- AVNW Nasdaq
- ESPR Nasdaq
- Market Cap
- AVNW 283.7M
- ESPR 319.2M
- IPO Year
- AVNW 2007
- ESPR 2013
- Fundamental
- Price
- AVNW $14.26
- ESPR $2.24
- Analyst Decision
- AVNW Strong Buy
- ESPR Buy
- Analyst Count
- AVNW 5
- ESPR 4
- Target Price
- AVNW $38.60
- ESPR $8.17
- AVG Volume (30 Days)
- AVNW 222.2K
- ESPR 3.4M
- Earning Date
- AVNW 11-05-2024
- ESPR 11-07-2024
- Dividend Yield
- AVNW N/A
- ESPR N/A
- EPS Growth
- AVNW N/A
- ESPR N/A
- EPS
- AVNW N/A
- ESPR N/A
- Revenue
- AVNW $409,603,000.00
- ESPR $295,451,000.00
- Revenue This Year
- AVNW $14.67
- ESPR $199.60
- Revenue Next Year
- AVNW $17.60
- ESPR $19.36
- P/E Ratio
- AVNW N/A
- ESPR N/A
- Revenue Growth
- AVNW 17.00
- ESPR 187.12
- 52 Week Low
- AVNW $12.96
- ESPR $0.87
- 52 Week High
- AVNW $38.85
- ESPR $3.40
- Technical
- Relative Strength Index (RSI)
- AVNW 21.38
- ESPR 54.58
- Support Level
- AVNW $12.96
- ESPR $2.05
- Resistance Level
- AVNW $20.95
- ESPR $2.25
- Average True Range (ATR)
- AVNW 0.92
- ESPR 0.12
- MACD
- AVNW -0.77
- ESPR -0.00
- Stochastic Oscillator
- AVNW 10.79
- ESPR 61.54
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.